DUOL vs SRPT · P/E 12, rev $590.4M vs rev $1.13B
Duolingo Inc (DUOL) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Duolingo Inc (DUOL) is a software - application company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported DUOL revenue for 2026-06-30 was $590.4M. Net income was $76.6M. DUOL currently screens at market cap $5.08B and trailing P/E 12.5.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
DUOL currently screens at market cap $5.08B and trailing P/E 12.5. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the DUOL and SRPT stock pages for the full models.
Not investment advice.